DZ3046A1 - Hydroxamides d'acides 3-(arylsulfonylamino)-tétrahydropyranne-3-carboxyliques, procédé pour leur préparation et compositions pharmaceutiques les contenant. - Google Patents

Hydroxamides d'acides 3-(arylsulfonylamino)-tétrahydropyranne-3-carboxyliques, procédé pour leur préparation et compositions pharmaceutiques les contenant.

Info

Publication number: DZ3046A1
Authority: DZ; Algeria
Prior art keywords: hydroxamides; arylsulfonylamino; tetrahydropyran; preparation; pharmaceutical compositions
Prior art date: 1999-05-28

Application number

DZ000090A

Other languages

English (en)

Inventor

Lawrence Alan Reiter

Original Assignee

Pfizer Prod Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-05-28

Filing date

2000-05-24

Publication date

2004-03-27

2000-05-24 Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc

2004-03-27 Application granted granted Critical

2004-03-27 Publication of DZ3046A1 publication Critical patent/DZ3046A1/fr

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/14—Nitrogen atoms not forming part of a nitro radical

DZ000090A 1999-05-28 2000-05-24 Hydroxamides d'acides 3-(arylsulfonylamino)-tétrahydropyranne-3-carboxyliques, procédé pour leur préparation et compositions pharmaceutiques les contenant. DZ3046A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US13653099P	1999-05-28	1999-05-28

Publications (1)

Publication Number	Publication Date
DZ3046A1 true DZ3046A1 (fr)	2004-03-27

Family

ID=22473239

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ000090A DZ3046A1 (fr)	1999-05-28	2000-05-24	Hydroxamides d'acides 3-(arylsulfonylamino)-tétrahydropyranne-3-carboxyliques, procédé pour leur préparation et compositions pharmaceutiques les contenant.

Country Status (22)

Country	Link
US (1)	US6197810B1 (fr)
EP (1)	EP1181286B1 (fr)
JP (1)	JP3784645B2 (fr)
AT (1)	ATE254119T1 (fr)
AU (1)	AU4424000A (fr)
BR (1)	BR0011539A (fr)
CA (1)	CA2375524C (fr)
DE (1)	DE60006523T2 (fr)
DK (1)	DK1181286T3 (fr)
DZ (1)	DZ3046A1 (fr)
ES (1)	ES2208315T3 (fr)
GT (1)	GT200000079A (fr)
HN (1)	HN2000000074A (fr)
MA (1)	MA26738A1 (fr)
MX (1)	MXPA01012265A (fr)
PA (1)	PA8495901A1 (fr)
PE (1)	PE20010170A1 (fr)
PT (1)	PT1181286E (fr)
SV (1)	SV2001000086A (fr)
TN (1)	TNSN00111A1 (fr)
UY (1)	UY26167A1 (fr)
WO (1)	WO2000073295A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040122011A1 (en) *	1998-12-23	2004-06-24	Pharmacia Corporation	Method of using a COX-2 inhibitor and a TACE inhibitors as a combination therapy
WO2001070693A2 (fr)	2000-03-21	2001-09-27	The Procter & Gamble Company	Inhibiteurs de metalloproteases d'acide difluorobutyrique
PL357250A1 (en) *	2000-03-21	2004-07-26	The Procter & Gamble Company	Heterocyclic side chain containing metalloprotease inhibitors
CA2404131A1 (fr)	2000-03-21	2001-09-27	The Procter & Gamble Company	Inhibiteurs de metalloproteases n-substitues renfermant une chaine laterale heterocyclique
US7019376B2 (en) *	2000-08-11	2006-03-28	Reflectivity, Inc	Micromirror array device with a small pitch size
US20030045449A1 (en) *	2001-08-15	2003-03-06	Pfizer, Inc.	Pharmaceutical combinations for the treatment of neurodegenerative diseases
GB0319069D0 (en) *	2003-08-14	2003-09-17	Glaxo Group Ltd	Therapeutically useful compounds
US20050058611A1 (en) *	2003-08-22	2005-03-17	L'oreal	Preventing and/or combating collagen fiber degradation induced under conditions of natural exposure to sunlight
PL2385938T3 (pl)	2009-01-12	2015-07-31	Pfizer Ltd	Pochodne sulfonamidu
CA2804173C (fr)	2010-07-09	2015-01-13	Pfizer Limited	Inhibiteurs de nav1.7 de type sulfonamide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5455258A (en) *	1993-01-06	1995-10-03	Ciba-Geigy Corporation	Arylsulfonamido-substituted hydroxamic acids
IL131042A (en)	1997-02-03	2004-07-25	Pfizer Prod Inc	Derivatives of arylsulfonamic acid hydroxyamic acid and medicinal preparations containing them
PA8469501A1 (es) *	1998-04-10	2000-09-29	Pfizer Prod Inc	Hidroxamidas del acido (4-arilsulfonilamino)-tetrahidropiran-4-carboxilico

2000
- 2000-05-15 CA CA002375524A patent/CA2375524C/fr not_active Expired - Fee Related
- 2000-05-15 AT AT00925520T patent/ATE254119T1/de not_active IP Right Cessation
- 2000-05-15 MX MXPA01012265A patent/MXPA01012265A/es active IP Right Grant
- 2000-05-15 PT PT00925520T patent/PT1181286E/pt unknown
- 2000-05-15 WO PCT/IB2000/000647 patent/WO2000073295A1/fr active IP Right Grant
- 2000-05-15 HN HN2000000074A patent/HN2000000074A/es unknown
- 2000-05-15 DE DE60006523T patent/DE60006523T2/de not_active Expired - Fee Related
- 2000-05-15 AU AU44240/00A patent/AU4424000A/en not_active Abandoned
- 2000-05-15 BR BR0011539-8A patent/BR0011539A/pt not_active IP Right Cessation
- 2000-05-15 JP JP2000621361A patent/JP3784645B2/ja not_active Expired - Fee Related
- 2000-05-15 DK DK00925520T patent/DK1181286T3/da active
- 2000-05-15 ES ES00925520T patent/ES2208315T3/es not_active Expired - Lifetime
- 2000-05-15 EP EP00925520A patent/EP1181286B1/fr not_active Expired - Lifetime
- 2000-05-19 PA PA20008495901A patent/PA8495901A1/es unknown
- 2000-05-24 TN TNTNSN00111A patent/TNSN00111A1/fr unknown
- 2000-05-24 DZ DZ000090A patent/DZ3046A1/fr active
- 2000-05-24 MA MA25988A patent/MA26738A1/fr unknown
- 2000-05-25 GT GT200000079A patent/GT200000079A/es unknown
- 2000-05-26 PE PE2000000507A patent/PE20010170A1/es not_active Application Discontinuation
- 2000-05-26 US US09/579,059 patent/US6197810B1/en not_active Expired - Fee Related
- 2000-05-26 SV SV2000000086A patent/SV2001000086A/es not_active Application Discontinuation
- 2000-05-26 UY UY26167A patent/UY26167A1/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
CA2375524A1 (fr)	2000-12-07
ATE254119T1 (de)	2003-11-15
AU4424000A (en)	2000-12-18
SV2001000086A (es)	2001-11-08
DK1181286T3 (da)	2004-02-16
JP3784645B2 (ja)	2006-06-14
MXPA01012265A (es)	2002-07-30
CA2375524C (fr)	2006-11-28
PE20010170A1 (es)	2001-02-27
JP2003500485A (ja)	2003-01-07
EP1181286B1 (fr)	2003-11-12
WO2000073295A1 (fr)	2000-12-07
DE60006523D1 (de)	2003-12-18
BR0011539A (pt)	2002-02-26
HN2000000074A (es)	2001-02-02
TNSN00111A1 (fr)	2002-05-30
UY26167A1 (es)	2000-12-29
MA26738A1 (fr)	2004-12-20
GT200000079A (es)	2001-11-16
DE60006523T2 (de)	2004-08-12
ES2208315T3 (es)	2004-06-16
US6197810B1 (en)	2001-03-06
EP1181286A1 (fr)	2002-02-27
PA8495901A1 (es)	2002-08-26
PT1181286E (pt)	2004-02-27

Publication	Publication Date	Title
MA26674A1 (fr)	2004-12-20	Derives d'hydroxamides heterocycliques nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
YU5201A (sh)	2003-07-07	Derivati hidroksipipekolathidroksamske kiseline kao inhibitori mmp
EA199900641A1 (ru)	2000-04-24	Производные арилсульфонилгидроксамовой кислоты
DZ3020A1 (fr)	2004-03-20	Acides oxamiques nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
MY121754A (en)	2006-02-28	Arylsulfonylamino hydroxamic acid derivatives
AP9801174A0 (en)	1998-01-31	Cyclic sulfone derivatives.
DZ3042A1 (fr)	2004-03-27	Dérivés d'isothiazole nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
GEP20053595B (en)	2005-08-10	Cyclopentanoindoles, Compositions Containing Such Compounds and Methods of Treatment
DZ3046A1 (fr)	2004-03-27	Hydroxamides d'acides 3-(arylsulfonylamino)-tétrahydropyranne-3-carboxyliques, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ3048A1 (fr)	2004-03-27	Précurseurs médicamenteux mutuels d'amlopidine et d'atorvastine, procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA26737A1 (fr)	2004-12-20	Hydroxamides d'acide 3-(arylsulfonylamino)-tetrahydrofuranne-3-carboxyliques, procede pour leur preparation et compositions pharmaceutiques les contenant
DZ3040A1 (fr)	2004-03-27	Benzolactames et thioamides cycliques substitués nouveaux, procédé pour préparation et compositions pharmaceutiques les contenant.